Search research articles
Contact Us
Filters
Showing results (131-140 of 183) with videos related to
Page
of 19
Sort By:
Journal of Crohn'S & Colitis
|
October 18, 2023
Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA
Marie Muller, Julien Broséus, Adrien Guilloteau, et al.
Alimentary Pharmacology & Therapeutics
|
March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study
Nicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Gut
|
April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence model
Anthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Gut
|
December 1, 2010
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study
Jessica Coelho, Laurent Beaugerie, Jean Frédéric Colombel, et al.
Journal of Crohn'S & Colitis
|
February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease
Marjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Therapeutic Advances in Gastroenterology
|
August 9, 2024
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
Bénédicte Caron, Philippe Seksik, Anthony Buisson, et al.
Journal of Autoimmunity
|
February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial
Roberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 22, 2008
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol, Bénédicte Pigneur, Laurie Watterlot, et al.
United European Gastroenterology Journal
|
November 18, 2021
Faster and less invasive tools to identify patients with ileal colonization by adherent-invasive E. coli in Crohn's disease
Anthony Buisson, Emilie Vazeille, Mathurin Fumery, et al.
Journal of Autoimmunity
|
October 2, 2024
Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases
Signe Hässler, Roberta Lorenzon, Marie Binvignat, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 183) with videos related to
Sort By:
Page
of 19
Journal of Crohn'S & Colitis
|
October 18, 2023
Lymphoma in Patients with Inflammatory Bowel Disease: A Multicentre Collaborative Study Between GETAID and LYSA
Marie Muller, Julien Broséus, Adrien Guilloteau, et al.
Alimentary Pharmacology & Therapeutics
|
March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study
Nicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Gut
|
April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence model
Anthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Gut
|
December 1, 2010
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study
Jessica Coelho, Laurent Beaugerie, Jean Frédéric Colombel, et al.
Journal of Crohn'S & Colitis
|
February 10, 2022
Identification of Gene Expression Profiles Associated with an Increased Risk of Post-Operative Recurrence in Crohn's Disease
Marjolaine Ngollo, Kevin Perez, Nassim Hammoudi, et al.
Therapeutic Advances in Gastroenterology
|
August 9, 2024
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
Bénédicte Caron, Philippe Seksik, Anthony Buisson, et al.
Journal of Autoimmunity
|
February 8, 2024
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial
Roberta Lorenzon, Claire Ribet, Fabien Pitoiset, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 22, 2008
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol, Bénédicte Pigneur, Laurie Watterlot, et al.
United European Gastroenterology Journal
|
November 18, 2021
Faster and less invasive tools to identify patients with ileal colonization by adherent-invasive E. coli in Crohn's disease
Anthony Buisson, Emilie Vazeille, Mathurin Fumery, et al.
Journal of Autoimmunity
|
October 2, 2024
Clinical correlates of lifetime and current comorbidity patterns in autoimmune and inflammatory diseases
Signe Hässler, Roberta Lorenzon, Marie Binvignat, et al.
Page
of 19